Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4-Reference-Cited by-同舟云学术

Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4

Published:2016-02-22 Issue:5 Volume:11 Page:785-794
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Ruggenenti Piero,Gentile Giorgio,Perico Norberto,Perna Annalisa,Barcella Luca,Trillini Matias,Cortinovis Monica,Ferrer Siles Claudia Patricia,Reyes Loaeza Jorge Arturo,Aparicio Maria Carolina,Fasolini Giorgio,Gaspari Flavio,Martinetti Davide,Carrara Fabiola,Rubis Nadia,Prandini Silvia,Caroli Anna,Sharma Kanishka,Antiga Luca,Remuzzi Andrea,Remuzzi Giuseppe

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference35 articles.

1. Autosomal Dominant Polycystic Kidney Disease

2. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys

3. PKD1 Induces p21waf1 and Regulation of the Cell Cycle via Direct Activation of the JAK-STAT Signaling Pathway in a Process Requiring PKD2

4. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease

5. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Glomerulus: Mechanisms and Patterns of Injury;Reference Module in Biomedical Sciences;2024

2. Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials;American Journal of Kidney Diseases;2023-11

3. Cystic Kidney Diseases in Children and Adults: Differences and Gaps in Clinical Management;Seminars in Nephrology;2023-11

4. Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges;Advances in Kidney Disease and Health;2023-05

5. A Systematic Review of Reported Outcomes in ADPKD Studies;Kidney International Reports;2022-09